Sponsored Content
|Articles|June 28, 2023
Are Nitrosamines a Concern for Biologic Manufacturers?
Author(s)SGS
This article provides an assessment of nitrosamine contamination specifically in biologics and contrasts the potential risks between these product types.
Related Content
Trending on Pharmaceutical Technology
1
Why Big Pharma Is Betting Billions on Protein Degraders for Cancer
2
Enhancing Clinical Data Infrastructure for AI Research: A Strategic Guide for Pharma Professionals
3
Investigating Patient Complaints About Combination Products
4
CPHI Americas: The Business Case for Product Carbon Footprints in Pharma
5